Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer
- Conditions
- Lung Cancer
- Registration Number
- NCT01799395
- Lead Sponsor
- Maggiore Bellaria Hospital, Bologna
- Brief Summary
Lung cancer may cause central airway obstruction through several different mechanisms (invasion by the primary tumor, invasion by metastatic lymph nodes, airway metastasis).
The aim of the present study is to determine the prevalence at the time of diagnosis, the incidence at 1 year from the diagnosis, and the predictors of central airway obstruction associated with advanced lung cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 45
- Advanced lung cancer with indication for chemotherapy or chemotherapy + radiation therapy
- Age < 18 year
- Pregnancy
- Refusal to sign informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of central airway obstruction 12 months The incidence will be measured over a 12 month period after diagnosis (or over the life span from diagnosis to death in patients who die before 1 year from the diagnosis)
- Secondary Outcome Measures
Name Time Method Predictor variables associated with the presence/occurrence of central airway obstruction 12 months Prevalence of central airway obstruction 1 day The prevalence of central airway obstruction will be evaluated at the time of diagnosis
Trial Locations
- Locations (5)
Bentivoglio Hospital
🇮🇹Bentivoglio, Emilia Romagna, Italy
Bellaria Hospital
🇮🇹Bologna, Emilia Romagna, Italy
SS Salvatore Hospital
🇮🇹San Giovanni in Persiceto, Emilia Romagna, Italy
Maggiore Hospital
🇮🇹Bologna, Emilia Romagna, Italy
Budrio Hospital
🇮🇹Budrio, Emilia Romagna, Italy